What you’ll learn:
- Without insurance, brand-name semaglutide can cost more than $1,000 per month, but NovoCare® offers lower self-pay prices starting at $149 for pills and $199 for injections.
- Wegovy® and Ozempic® pills typically cost up to $299 per month through NovoCare®, while injections cost $349 at most doses after introductory discounts.
- Which brand you can use depends on your diagnosis, and eligible people may pay as little as $25 per month with commercial insurance or $50 through the Medicare GLP-1 Bridge program.
Semaglutide is one of the most widely prescribed GLP-1 medications in the U.S. You most likely know it as Ozempic® or Wegovy®, which both share it as the active ingredient.
Wegovy® is available for weight loss in two forms: a weekly injection and a daily pill. Wegovy® can also be prescribed for heart disease prevention and MASH, a liver condition. Ozempic® is available as an injection and a pill and is approved for diabetes management.
These different names and approvals are important when an insurance company is assessing whether your use can be covered.
Why? While both medications might be covered by insurance for other FDA-approved uses, weight loss isn’t required by law to be covered, so insurance companies can opt out. In the case of Medicare, weight-loss medications are now covered under the Medicare GLP-1 Bridge program, a temporary federal pilot running through December 31, 2027. It lets eligible Medicare Part D beneficiaries access certain GLP-1s, including Zepbound® and Wegovy®, for a flat $50/month copay. See if you might qualify and how it works.
For anyone paying out of pocket, which is most people who are prescribed semaglutide for weight loss, understanding what they’ll pay per month without insurance is important. And for both medications, this will depend on the current dose.
Let’s break down what semaglutide costs without insurance in 2027 and find your best opportunities to save.
How much does semaglutide cost per month without insurance?
While the list price is over $1,000 for both Ozempic® and Wegovy®, most people won’t pay these prices, even without insurance. Without insurance, most people will fill their prescription for semaglutide through the NovoCare Pharmacy or through a pharmacy that partners with them.
Which price applies to you depends on your diagnosis.
Ozempic® is approved for type 2 diabetes, not when it is prescribed off-label for weight loss. NovoCare pricing for Ozempic® is only available to people prescribed Ozempic® for an FDA-approved use, and all of those uses are for type 2 diabetes.
Wegovy® is approved for weight management and heart disease risk reduction.
A prescription is written for a diagnosis, so the price that applies to you is the one for the brand your clinician prescribes.
Here’s a look at what to expect:
Price snapshot (estimated monthly costs)
| Medication | Weekly injection (NovoCare Pharmacy) | Daily pill (NovoCare Pharmacy) | Medicare GLP-1 Bridge | List price (before any program) |
|---|---|---|---|---|
| Wegovy® | $199: 0.25 mg and 0.5 mg (first two monthly fills; $349 after) $349: 1 mg, 1.7 mg, and 2.4 mg $399: 7.2 mg | $149: 1.5 mg $199: 4 mg $299: 9 mg and 25 mg | $50 (all doses) | $1,349.02 (all doses) |
| Ozempic® (for type 2 diabetes only) | $199: 0.25 mg and 0.5 mg (first two monthly fills; $349 after) $349: 1 mg $499: 2 mg | $149: 1.5 mg $199: 4 mg $299: 9 mg | Not covered by the Bridge; may be covered by Part D | $1,027.51 |
Other costs of getting prescribed semaglutide
On top of medication costs, semaglutide typically requires ongoing medical care: initial provider consultations, dose titration check-ins, periodic lab work, and prescription renewals. When these are billed separately, they can push your monthly spend higher. Programs that bundle care with the prescription can make costs far easier to predict.
The cheapest way to get semaglutide without insurance in 2027
The cheapest semaglutide options without insurance are available through NovoCare Pharmacy, but costs typically increase as you move up from the starting doses:
- Pill: The cheapest option is the 1.5 mg Wegovy® pill—or the 1.5 mg Ozempic® pill for type 2 diabetes—at $149 per month. But these are starting doses, and costs typically increase as you move up. For long-term treatment, many people can expect to pay around $299 per month.
- Injection: The $199 introductory price for Wegovy® injections applies only to the first two fills. For long-term treatment, many people can expect to pay around $349 per month.
Your provider may recommend staying at a lower dose longer to manage side effects, so your costs may vary. Here’s how monthly prices compare as you move through the typical dosing schedule for Wegovy® pills and injections.
| Estimated treatment weeks | Pill (daily) | Injection (weekly) |
|---|---|---|
| Weeks 1–4 | 1.5 mg: $149/month | 0.25 mg: $199/month* |
| Weeks 5–8 | 4 mg: $199/month | 0.5 mg: $199/month* |
| Weeks 9–12 | 9 mg: $299/month | 1 mg: $349/month |
| Weeks 13–16 | 25 mg: $299/month | 1.7 mg: $349/month |
| Week 17 onward | 25 mg: $299/month | 2.4 mg: $349/month |
| Higher-dose option | — | Wegovy® HD 7.2 mg: $399/month |
NovoCare says its pricing will be updated after December 31, 2026, so check NovoCare.com before you fill.
Best price for semaglutide by dose
Semaglutide prices generally increase as you move up in dose, though the cost depends on whether you take a pill or injection.
- Pills: Wegovy® starts at $149 per month for 1.5 mg, increases to $199 for 4 mg, and costs $299 for 9 mg and 25 mg.
- Injections: Wegovy® starts at $199 per month for the first two fills for eligible new patients, then costs $349 at most doses.
These are manufacturer self-pay prices. Ozempic® has different pricing at some doses and is approved for type 2 diabetes, not weight loss. See the full price table above for a dose-by-dose comparison.
Where to buy semaglutide without insurance: Cheapest pharmacies
The cheapest place to buy brand-name semaglutide without insurance is NovoCare Pharmacy, where self-pay prices range from $149 to $499 per month, depending on the medication and dose.
You can have your prescription delivered for free or arrange pickup at a participating local pharmacy. Novo Nordisk has also said that NovoCare prescriptions can be picked up at CVS locations.
Without manufacturer savings, pharmacy cash prices can be significantly higher. Ask your pharmacy whether it can process the NovoCare self-pay offer before filling your prescription.
For a pharmacy-by-pharmacy comparison, see Semaglutide cost without insurance: Pharmacy choice.
Buying semaglutide online: The best sources
You can buy semaglutide online through NovoCare Pharmacy or another licensed pharmacy with a valid prescription. NovoCare offers home delivery, so you don’t need to visit a pharmacy to pick up your medication.
Be cautious of websites selling semaglutide without a prescription or advertising prices far below the manufacturer’s lowest self-pay price of $149 per month. These offers may involve compounded products, unapproved medications, or counterfeit drugs.
Semaglutide on TrumpRx
TrumpRx lists discounted cash prices for Wegovy® and Ozempic®, starting at $149 per month for the Wegovy® pill and $199 for introductory injection fills.
However, TrumpRx doesn’t sell medications directly. It directs you to NovoCare or provides a pharmacy coupon to access the manufacturer’s discounted prices. That means you generally won’t save more by going through TrumpRx instead of NovoCare.
TrumpRx prices are for people paying out of pocket, not using insurance.
Will semaglutide get cheaper in 2027?
Semaglutide prices have already dropped. On November 17, 2025, Novo Nordisk reduced the standard self-pay price for Wegovy® and Ozempic® injections from $499 to $349 per month.
More changes are coming in 2027:
- January 1, 2027: Novo Nordisk will lower the U.S. list price of Wegovy® and Ozempic® to $675 per month. This doesn’t automatically lower manufacturer self-pay prices.
- January 1, 2027: Medicare’s negotiated price for certain semaglutide products takes effect, which may lower costs for eligible beneficiaries.
- After December 31, 2026: NovoCare’s current self-pay offers are scheduled to be updated, so 2027 prices may differ.
There is still no FDA-approved generic semaglutide, so manufacturer savings programs remain an important way to reduce out-of-pocket costs.
Semaglutide cost: News and changes for 2026-2027
When you’re paying out of pocket for medication, pricing shifts can directly affect what you spend each month. In 2026, several major developments are reshaping the semaglutide cost landscape—and some of them create real opportunities to pay less.
What’s changing on January 1, 2027: Two events that affect semaglutide pricing
On January 1, 2027, two changes take effect. Neither changes what most people pay with cash.
- Novo Nordisk’s list price drops to $675 per month for the Wegovy® 2.4 mg injection and 25 mg tablets and the Ozempic® 0.5 mg, 1 mg, and 2 mg injections. That’s roughly 50% for Wegovy® and 35% for Ozempic®. The Ozempic® pill wasn’t named, and Novo Nordisk hasn’t confirmed whether it’s included.
- Medicare’s negotiated price for semaglutide is $274 per 30-day supply, 71% below the $959 CMS benchmark. This is what Part D plans pay, not what you pay at the counter.
- December 31, 2026: NovoCare’s current self-pay offers are dated through this day, including the $199 introductory price for new patients on the lowest injection doses. NovoCare says pricing will be updated after this date, so check NovoCare.com before you fill.
Novo Nordisk says the list-price change doesn’t affect self-pay prices, and the $50 Bridge copay continues through December 31, 2027. NovoCare’s current offers are dated through December 31, 2026, so check NovoCare.com for updated pricing.
Other important Wegovy cost events in 2026
- August 31, 2026: Promotional pricing for the Wegovy® 4 mg pill dose has ended. The $149 per month price applied to prescriptions written on or before this date, and the 4 mg tablet is now $199 per month. Higher maintenance doses (9 mg and 25 mg) remain at $299 per month through NovoCare® Pharmacy. (Edit: the original said the price “is expected to increase”; the date has passed and the increase is confirmed on wegovy.com. The last sentence is unchanged.)
- July 1, 2026–December 31, 2027: Medicare GLP-1 Bridge Program runs nationwide. Eligible Medicare beneficiaries can access select GLP-1 medications, including the Wegovy® injection and pill for weight management, for $50 per month. Learn more: How the Medicare GLP-1 Bridge works and who’s eligible | Check your eligibility
- May 4, 2026: Rybelsus® is rebranded as the Ozempic® pill and becomes available through NovoCare® Pharmacy at reduced cash-pay pricing.
- March 19, 2026: FDA approves Wegovy® HD (semaglutide 7.2 mg injection). The 7.2 mg dose provides a step beyond the 2.4 mg dose. Wegovy® HD is available through NovoCare® Pharmacy at $399 per month and launched in pharmacies in April 2026.
- February 24, 2026: Novo Nordisk announces list price cuts of up to 50%, effective January 1, 2027.
- February 5, 2026: TrumpRx.gov launches with Ozempic® and Wegovy® listed. It’s a cash-only site that points you to NovoCare or a pharmacy coupon, and it doesn’t accept insurance.
- January–March 2026: Novo Nordisk expands NovoCare® Pharmacy self-pay pricing. Structured cash-pay tiers rolled out for Wegovy® and Ozempic®. New customers starting on lower doses could access their first two monthly fills at $199, with ongoing pricing ranging from $349 to $499 per month, depending on the medication, dose, and formulation.
- December 22, 2025: FDA approves the Wegovy® oral tablet for weight management.
Learn more: Ozempic® cost without insurance | Wegovy® cost without insurance
Semaglutide cost without insurance: Pharmacy choice
For most people paying cash, pharmacy choice matters less than you might expect. Major retail chains now partner directly with NovoCare®, Novo Nordisk’s discount program, which is why you’ll see consistent pricing across retailers.
NovoCare® Pharmacy offers cash-pay pricing that’s often significantly lower than the standard list price. Prices vary by medication and dose, and some introductory rates apply only for the first couple of months.
Who is eligible for NovoCare pricing?
NovoCare cash-pay pricing is available to people who:
- Are paying out of pocket (no insurance billing for the prescription)
- Have a valid prescription for Ozempic® or Wegovy®
- Are prescribed Ozempic® or Wegovy® for an FDA-approved use, which means weight loss, MASH, or heart disease for Wegovy and type 2 diabetes for Ozempic. NovoCare’s Ozempic® prices aren’t available for weight management.
- Aren’t submitting the prescription to insurance. People with Medicare, Medicaid, or TRICARE can still pay cash, but the fill can’t be billed to their plan or counted toward their deductible.
Eligibility requirements may vary and are subject to change. Always check NovoCare.com for current terms.
Here’s how semaglutide prices compare across popular pharmacies and programs as of early 2026. As you can see, they are now all partnering with NovoCare and have the same pricing.
| Retailer / Pharmacy | Wegovy® (injection) | Wegovy® pill | Ozempic® (injection) | Ozempic® pill |
|---|---|---|---|---|
| CVS | $199-$399 | $149-$299* | $199-$499 | $149-$299* |
| Walgreens | $199-$399 | $149-$299* | $199-$499 | $149-$299* |
| Walmart | $199-$399 | $149-$299* | $199-$499 | $149-$299* |
| Costco | $199-$399 | $149-$299* | $199-$499 | $149-$299* |
| Target | $199-$399 | $149–$299* | $199-$499 | $149–$299* |
Disclaimer: Actual prices may vary by dose, location, formulation, and availability. NovoCare® cash-pay pricing represents manufacturer programs and may have eligibility requirements.
Are there savings cards for semaglutide?
Yes—and they can reduce what you pay, depending on your insurance situation. Novo Nordisk offers savings cards for Ozempic® and Wegovy® that work differently depending on whether you have commercial insurance and whether your plan covers the specific medication.
How the savings card works with commercial insurance
If you have commercial (employer-sponsored or private) insurance and your plan covers the semaglutide medication you’re prescribed, the manufacturer’s savings card can bring your monthly cost down to as low as $25 per month. This applies to both Ozempic® and Wegovy® pills and injections.
You may qualify if:
- You have commercial or employer-sponsored prescription insurance
- Your insurance plan covers the specific semaglutide medication prescribed
- You live in the U.S. or a U.S. territory and are 18 or older
You aren’t eligible if:
- You are enrolled in Medicare, Medicaid, TRICARE, VA, or other government-funded programs
- You are uninsured or paying entirely in cash
- Your insurance plan doesn’t cover the prescribed medication
How to use the Wegovy® savings card
- Step 1: Visit NovoCare or text SAVE to 83757 to enroll in the Wegovy® Savings Offer. The card covers both the injection and the pill.
- Step 2: Verify you have commercial insurance that covers Wegovy®. Medicare, Medicaid, TRICARE, VA, and all other government program enrollees are not eligible.
- Step 3: Present the savings card along with your insurance card at the pharmacy when you fill your prescription. The pharmacy processes your insurance first, then applies the card—bringing your copay down to as little as $25 per month.
- Step 4: Recheck eligibility at every refill. Terms, benefit caps, and eligibility criteria can change. Verify current requirements before counting on a specific price.
Does the savings card work if my insurance doesn’t cover Wegovy?
If your insurance denies coverage, the $25 savings card rate is no longer available to you. Instead, you can access NovoCare® self-pay pricing, currently $149 to $399 per month depending on dose. That’s still significantly less than the $1,349 list price, but it’s a different program with different pricing.
How to use the Ozempic® savings card
- Step 1: Visit NovoCare to enroll in the Ozempic® Diabetes Savings Offer. The card covers both the injection and the pill.
- Step 2: Verify you have commercial insurance that covers Ozempic® for type 2 diabetes. Medicare, Medicaid, TRICARE, VA, and all other government program enrollees aren’t eligible.
- Step 3: Present the savings card along with your insurance card at the pharmacy when you fill your prescription. The pharmacy processes your insurance first, then applies the card.
- Step 4: Recheck eligibility at every refill. If you’ve recently switched from the Ozempic® injection to the Ozempic® pill, confirm whether re-enrollment is required, as these are treated as separate fills under the program.
Ways to lower your monthly semaglutide cost without insurance
Several practical strategies can reduce your monthly expenses—sometimes by hundreds of dollars. The most effective approach usually involves combining a few of these methods rather than relying on any single one.
- Use NovoCare® Pharmacy’s cash-pay pricing. This is currently the most direct way to access brand-name semaglutide at a reduced cost. With introductory pricing for new customers and ongoing rates well below retail, it’s worth checking whether you qualify before filling at a traditional pharmacy.
- Order a 90-day supply when possible. Some pharmacy programs reduce per-unit costs when you order a larger supply. This can also cut down on dispensing fees and the number of trips to the pharmacy.
- Pay with HSA or FSA funds. If you have a Health Savings Account or Flexible Spending Account, prescription semaglutide qualifies for tax-advantaged spending. The price at the pharmacy stays the same, but using pre-tax dollars effectively lowers your real cost. This covers the medication itself, related lab work, and doctor visits. Keep your receipts for tax purposes.
- Apply for patient assistance programs. Novo Nordisk’s Patient Assistance Program (PAP) through NovoCare provides Ozempic® (injection) for type 2 diabetes at no cost to eligible people. To qualify, you must be uninsured or on Medicare without active Part D drug coverage, and your household income must be at or below 200% of the federal poverty level (approximately $31,920/year for a single person in 2026). Wegovy® is not covered by the PAP in any form. The coverage status of the Ozempic® pill under the PAP has not been confirmed since its May 2026 launch.
- Consider bundled care programs. Noom combines prescription access with clinician supervision and behavioral support in a predictable monthly fee. When clinician visits, follow-ups, and prescription management are bundled rather than billed separately, total monthly costs become easier to plan for—and sometimes lower overall.
Insurance coverage for semaglutide: Eligibility and costs
Insurance coverage for semaglutide varies significantly depending on your specific plan, why your doctor is prescribing it, and which brand and form of semaglutide you need. When insurance does cover the medication, monthly copays typically range from $0 to $150.
Coverage depends on the diagnosis. Insurance companies treat semaglutide differently based on whether it’s prescribed for type 2 diabetes, another issue, or weight management. Many plans cover Ozempic® when prescribed for diabetes, but it won’t be covered for off-label weight loss. Wegovy® may be covered for heart disease prevention or MASH, but it’s less likely for weight loss.
Does Medicare cover semaglutide?
Medicare follows different rules, and coverage depends on the diagnosis and the specific drug.
Medicare Part D may cover Ozempic® when prescribed for type 2 diabetes and Wegovy® when prescribed to reduce cardiovascular risk or MASH.
For both, prior authorization and other documentation are often required.
The Medicare GLP-1 Bridge demo program, which launched July 1, 2026, now offers some people coverage. The Wegovy® pill and injection are available for $50 per month through December 2027 for those who qualify. Learn how the Bridge program works or check your eligibility.
To qualify, a person must be enrolled in a Medicare Part D plan and meet one of three clinical criteria—assessed at the time you first started GLP-1 therapy, not at the time you apply:
- BMI of 35 or higher (no additional diagnosis required)
- BMI of 30 or higher, plus a diagnosis of heart failure with preserved ejection fraction, uncontrolled hypertension on two or more blood pressure medications, or chronic kidney disease stage 3a or higher
- BMI of 27 or higher, plus a diagnosis of pre-diabetes, previous heart attack, previous stroke, or symptomatic peripheral artery disease
Your provider submits a prior authorization request attesting you meet the criteria—you don’t need to opt in or take any action yourself. If you’re interested in pursuing GLP-1 treatment through the Bridge program, you can also get started through Noom, which can help connect you with a provider and guide you through eligibility.
If you have type 2 diabetes: Bridge is for weight management only. CMS routes people with type 2 diabetes to standard Part D coverage instead, so Ozempic® (injection or pill) is covered through your Part D plan, usually with prior authorization. In 2026, Part D has a $615 deductible and caps your annual out-of-pocket spending at $2,100.
Medicaid coverage for semaglutide
Coverage varies by state. Most state Medicaid programs cover Ozempic® for type 2 diabetes, often with low copays. Wegovy® may be covered for heart disease prevention or MASH, but coverage for weight management is less consistent—some states cover it, others don’t.
The key distinction: Medicare coverage rules are set at the federal level, while Medicaid policies are determined state by state, which is why coverage can vary dramatically depending on where you live.
Learn more:
How to get a prescription for semaglutide without insurance
There are multiple ways to connect with a licensed clinician who can prescribe semaglutide—both in person and online. Costs vary depending on the route you take, and telehealth has made the process faster and more convenient. Still, comparing options is worth your time.
- Primary care doctor (in person) – Most primary care providers can prescribe semaglutide if it’s medically appropriate. Without insurance, expect to pay out of pocket for office visits ($200–$400 for an initial consultation), follow-ups ($100–$200 each), and any required lab work. These are typically billed separately.
- Endocrinologist or weight management specialist – Specialists may have deeper experience with GLP-1 medications, but they’re often the most expensive route. Initial visits can run several hundred dollars, with additional fees for each follow-up and lab panel.
- Telehealth weight management programs – Telehealth companies connect you with licensed clinicians through virtual visits. If you’re eligible for medication through Noom, you’ll meet virtually with a licensed provider who reviews your health history and can prescribe semaglutide when appropriate. The program then pairs prescription weight management care with coaching and behavior-change support. You’ll also receive guidance around nutrition, movement, and lifestyle—so medication is part of a broader, sustainable approach.
The advantages of telehealth
For people paying out of pocket, telehealth can offer a more predictable way to access prescription weight management care. Instead of paying separately for each visit or navigating referrals between providers, Noom combines clinician evaluation, prescription support, and behavior-change tools in one place.
Who is eligible for medication through Noom?
Noom Med is built for people who want more than just a prescription. After you complete a health assessment, a licensed clinician reviews your medical history to see if semaglutide or another treatment makes sense for you.
It may be a good option if:
- You’ve had trouble losing weight with diet and exercise alone
- You want medical guidance alongside structured behavior-change support
- You’re looking for a more guided, long-term approach
Not sure if you qualify? You can check eligibility by completing Noom’s intake questionnaire.
Why you need a prescription for semaglutide
Semaglutide is a prescription-only medication, whether it’s prescribed as Ozempic® or Wegovy®. You can’t buy it over the counter or order it online without a clinician’s authorization. This is because semaglutide affects blood sugar regulation, appetite signaling, and gastric emptying—all of which require medical oversight to manage safely.
A provider reviews your medical history, screens for conditions that could make semaglutide risky, and monitors how your body responds as the dose changes. That medical supervision helps make sure the medication is both effective and safe. Here are some specific reasons why:
Semaglutide requires careful dose titration
Semaglutide is started at a low dose and increased gradually over several months. This slow ramp-up gives your body time to adjust and helps minimize common side effects like nausea, constipation, and diarrhea.
Your provider adjusts the schedule based on how you’re tolerating the medication and whether it’s producing the expected results. Skipping this process or starting at too high a dose can cause significant gastrointestinal side effects.
Side effects need monitoring
Like other GLP-1 medications, semaglutide can cause side effects—especially during the first weeks of treatment or when the dose goes up. These are typically moderate and are most likely when starting the medication or when increasing the dose.
Common side effects include:
- Nausea (the most common, usually first to emerge)
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain or discomfort
Semaglutide is also associated with serious but less common side effects that require prompt medical attention, which makes clinician oversight essential.
Serious but uncommon side effects of semaglutide include pancreatitis, gallbladder disease (including gallstones and gallbladder inflammation), acute kidney injury, worsening diabetic retinopathy in people with existing eye disease, hypoglycemia when used with insulin or sulfonylureas, and severe allergic reactions such as anaphylaxis or angioedema.
Thyroid tumor warning: All semaglutide medications also carry an FDA boxed warning for a potential risk of thyroid C-cell tumors based on animal studies, although it is unknown whether this risk applies to humans.
Learn more: Semaglutide side effects: Symptom guide & management tips
Some people shouldn’t take semaglutide
Semaglutide isn’t appropriate for everyone. A medical review before starting treatment is essential. You shouldn’t take semaglutide if:
- You or a family member has a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
- You’ve had a serious allergic reaction to semaglutide or any ingredient in the medication.
- You are pregnant, planning to become pregnant, or breastfeeding.
Your provider may also recommend against semaglutide if you have a history of pancreatitis, impaired kidney function, or take medications whose absorption could be affected by delayed gastric emptying.
Read more: Semaglutide side effects: What to expect and how to manage them
Frequently asked questions about the cost of semaglutide without insurance
The cost of semaglutide without insurance can vary widely depending on the medication, pharmacy, and available savings options. With multiple pricing pathways to consider, it can be difficult to know where to start or how to find the lowest cost.
The following frequently asked questions address common concerns and provide clear guidance on ways to manage out-of-pocket expenses.
Is Ozempic semaglutide?
Yes. Ozempic® is a brand name; semaglutide is the active ingredient. Novo Nordisk also sells semaglutide as Wegovy®. Ozempic® (injection and pill) is approved for type 2 diabetes, and Wegovy® (injection and pill) is approved for chronic weight management and heart disease risk reduction. Because insurers and savings programs apply by diagnosis, it’s important that you know which brand you’ve been prescribed.
Which is cheaper, Ozempic or Wegovy?
The prices are comparable through NovoCare® Pharmacy. The injections run $349 per month for most doses of either brand (Ozempic® 2 mg is $499, Wegovy® HD is $399), and the pills run $149 to $299. Your clinician prescribes the brand that matches your diagnosis, and NovoCare’s Ozempic® prices apply only to people with type 2 diabetes.
What is the cheapest way to get semaglutide without insurance?
For most people paying out of pocket, the most affordable route to brand-name semaglutide is through Novo Nordisk’s NovoCare® Pharmacy cash-pay program—and the lowest entry point right now is the Wegovy® pill.
At $149/month for the 1.5 mg starter dose, the oral Wegovy® pill is currently the cheapest way to start brand-name semaglutide without insurance.
Note: The limited-time $149 price on the 4 mg dose ended after August 31, 2026; 4 mg is now $199/month.
Does the $25 savings card work if I have no insurance?
No. Novo Nordisk’s savings programs require commercial insurance that covers the prescribed medication to reach $25 per month. There are two separate cards depending on which medication you’re prescribed:
- Wegovy® Savings Offer—for Wegovy® (injection or pill) prescribed for weight management or cardiovascular risk reduction.
- Ozempic® Diabetes Savings Offer—for Ozempic® (injection or pill) prescribed for type 2 diabetes only.
Can I use the Ozempic savings card if I have Medicare?
No. Novo Nordisk’s savings offers exclude people enrolled in Medicare (including Part D), Medicaid, VA, TRICARE, and similar programs, although you can still pay NovoCare’s cash prices outside your insurance. If you have Medicare, Wegovy® for weight management is available for $50 per month through the Medicare GLP-1 Bridge for those who qualify, and Ozempic® for type 2 diabetes goes through standard Part D coverage.
Does the monthly cost of semaglutide include doctor visits?
No. The medication price you see—whether retail or through a cash-pay program—doesn’t include the cost of doctor visits, lab work, or follow-up appointments. Traditional in-person care can add $200 to $400 per month in visit and lab fees. Noom charges a flat monthly fee that includes clinician consultations, making total costs more predictable.
Can I use HSA or FSA money for semaglutide?
Yes. Prescription semaglutide qualifies for HSA and FSA spending when prescribed by a licensed provider, regardless of whether it’s for diabetes or weight management. This includes the medication cost, related lab work, and provider visits. Keep all receipts for tax documentation, and check with your benefits administrator about any specific plan requirements.
Is the Wegovy® pill cheaper than the injection?
Both forms have a retail list price of about $1,350 per month and qualify for the same savings offer of as little as $25 per month with eligible commercial insurance.
If you’re paying out of pocket through NovoCare® Pharmacy, the Wegovy® pill is generally cheaper:
- Wegovy® pill: $149–299 per month, depending on the dose.
- Wegovy® injection: $199–399 per month, depending on the dose.
But cost isn’t the only consideration. The pill may be close to the effectiveness of the 2.4 mg injection, but it may lead to less weight loss than the higher-dose 7.2 mg Wegovy® HD injection. In separate clinical trials, people taking the 25 mg pill lost about 14% of their body weight, compared with approximately 18.7% for Wegovy® HD. These weren’t head-to-head studies, so results aren’t directly comparable.
Learn more: Wegovy® pill vs. injection: How do they compare? and Wegovy® HD 7.2 mg: Weight loss results
Will generic semaglutide be available soon?
Not soon. Novo Nordisk holds patents on semaglutide through approximately 2031–2032, and generic versions aren’t expected until the early-to-mid 2030s. In the meantime, your best options for lowering costs are manufacturer cash-pay programs through NovoCare®, savings cards (if you have commercial insurance), and shopping for the most favorable pharmacy pricing.
Is semaglutide getting cheaper in 2027?
Partly. On January 1, 2027, Novo Nordisk’s list price drops to $675 per month for certain Wegovy® and Ozempic® formulations, and Medicare’s negotiated price for semaglutide takes effect at $274 per 30-day supply. Novo Nordisk says the list-price change doesn’t affect self-pay prices, so most people paying cash won’t see a direct change.
Can I get semaglutide for free?
Possibly, if you meet specific criteria, but only for type 2 diabetes, not weight loss. Novo Nordisk’s Patient Assistance Program (PAP) through NovoCare provides Ozempic® at no cost to eligible patients managing type 2 diabetes.
To qualify:
- You must be uninsured, or on Medicare without active Part D drug coverage—patients with commercial insurance are not eligible
- Your household income must be at or below 200% of the federal poverty level (approximately $31,920/year for a single person in 2026)
- You must not be enrolled in Medicaid, Medicare Low Income Subsidy (Extra Help), VA Benefits, or any other government assistance program
What’s not covered:
- Wegovy® (injection or tablet) for weight management—there is no free medication program for semaglutide prescribed for weight loss
- The Ozempic® pill PAP coverage status has not been confirmed since its May 2026 launch.
For the most current list of covered products and eligibility requirements, check NovoCare.com.
The bottom line: What you’ll actually pay for semaglutide depends on prescription and maintenance dose
Semaglutide can be expensive without insurance, but people don’t typically pay the full list price. Through NovoCare® Pharmacy, brand-name semaglutide starts at $149 per month for the lowest-dose pill, while most injection doses cost $349 per month. Your actual cost depends on whether you’re prescribed Wegovy® or Ozempic®, the form you take, and your maintenance dose.
The best way to save is to start with the manufacturer’s self-pay program and check whether you qualify for additional assistance. If you have commercial insurance that covers your medication, a savings card could bring your cost down to $25 per month. Eligible Medicare beneficiaries may also be able to get Wegovy® for $50 per month through the GLP-1 Bridge program.
With more formulations, expanded savings programs, and pricing changes coming in 2027, semaglutide is becoming more affordable for some people. Just remember that the lowest starting price isn’t necessarily what you’ll pay long-term. Check your expected maintenance-dose cost, along with any provider fees, so you can find an option that fits your budget and supports consistent treatment.
If you’re looking for weight loss support that goes beyond just the prescription, see if you qualify for medication through Noom. You’ll be connected to a clinician who can find the right medication for you and prescribe it if needed. The program will then pair medication management with psychology-based coaching, exercise guidance, and more—all designed to help you build habits that last.
Note: Ozempic® isn’t FDA-approved for weight management.
Editorial standards
At Noom, we’re committed to providing health information that’s grounded in reliable science and expert review. Our content is created with the support of qualified professionals and based on well-established research from trusted medical and scientific organizations. Learn more about the experts behind our content on our Health Expert Team page.




























